EUVIMEDEUVIMED entdecken
EditorialOpen Access

Putting Methylphenidate for Cancer-Related Fatigue to Rest?

Nicolas Chin-Yee iD, Sriram Yennurajalingam iD, Camilla Zimmermann iD

Journal of Clinical Oncology · 10.07.2024 · 42 (20) · 2363-2366

DOI: 10.1200/jco.24.00707 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.07.2024. Verfasst von Nicolas Chin-Yee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. Hauptthemen laut MEDLINE: Methylphenidate, Fatigue, Neoplasms, Central Nervous System Stimulants. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the article that accompanies this editorial, Stone et al. present a randomized, double-blind, placebo-controlled trial of individually dose-titrated methylphenidate for treatment of fatigue in patients with advanced cancer, finding that methylphenidate, while safe and well-tolerated, was no more effective than placebo at relieving fatigue after 6 (±2) weeks. Future studies should consider the multifaceted nature of cancer-related fatigue, as well as the substantial placebo effects of psychostimulants, and may benefit from focusing on methylphenidate in combination with non-pharmacological interventions, or for fatigue with a predominant emotional or cognitive component.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethylphenidateFatigueNeoplasmsCentral Nervous System StimulantsHumans

Substanzen

MethylphenidateCentral Nervous System Stimulants

Autor:innen und Institutionen

  • Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Division of Palliative Medicine, Department of Medicine, University of Toronto, Toronto, Canada.
  • The University of Texas MD Anderson Cancer Center, Houston, TX.

ORCID-Profile: Nicolas Chin-Yee, Sriram Yennurajalingam, Camilla Zimmermann

Förderung

  • NCI NIH HHS

Zitieren

APA

Chin-Yee, N., Yennurajalingam, S., & Zimmermann, C. (2024). Putting Methylphenidate for Cancer-Related Fatigue to Rest?. Journal of Clinical Oncology, 42(20), 2363-2366. https://doi.org/10.1200/jco.24.00707

Vancouver

Chin-Yee N, Yennurajalingam S, Zimmermann C. Putting Methylphenidate for Cancer-Related Fatigue to Rest?. Journal of Clinical Oncology. 2024;42(20):2363-2366. doi:10.1200/jco.24.00707

BibTeX
@article{ChinYee2024,
  author = {Chin-Yee, Nicolas and Yennurajalingam, Sriram and Zimmermann, Camilla},
  title = {Putting Methylphenidate for Cancer-Related Fatigue to Rest?},
  journal = {Journal of Clinical Oncology},
  year = {2024},
  volume = {42},
  number = {20},
  pages = {2363--2366},
  doi = {10.1200/jco.24.00707}
}
Kostenlos starten →